Mon - Fri 09:00-18:00 0207 060 3773
Email info@boundarycapital.com

By

admin
Managing Partner of Boundary Capital, Dan Somers, was recently interviewed by and joined a panel of experts on, the GrowthInvest Adviser Hour. GrowthInvest is the tax efficient investment platform for financial advisers and high net worth and sophisticated investors, is delighted to present, in association with Capital Connections. Now into its second series, the program...
Read More
Boundary Capital is delighted to be presenting at the Kuber Ventures seminar at The Royal Automobile Club 5 July. EIS is set to play a critical role in the growth of the UK economy and both understanding and managing risk is central to this exciting dynamic growth oriented environment. Join us and Kuber Ventures at...
Read More
Boundary Capital has announced its exit for the bulk of its holdings in AIM listed Image Scan Holdings Plc. The exit has returned four times the original investment for investors, after only three years. Boundary Capital has invested in a number of assets in technology and life sciences covering big data analytics, left science therapeutics...
Read More
Our Managing Partner Dan Somers talks to Finance Digital talking about why some investors are going the extra mile. Investing in early stage technology businesses is a risky business. If you get it right investing in a disruptive business like WhatsApp or Alibaba can generate huge exits: a whopping $22Bn and $25Bn respectively (Sequoia Capital turned...
Read More
Boundary Capital has seen the price of its shares in Image Scan Holdings plc grow by five and a half times since their initial investment three years ago due to the stellar development and growth of Image Scan. Image Scan, the specialist supplier of X-ray screening systems to the security and industrial inspection markets is...
Read More
What Investment has published the latest news from Boundary Capital’s portfolio company AB Polyblok. Boundary Capital investment company AB-Polyblok has today filed a patent application following the results of in-vitro & in-vivo experiments that have shown that their drug appears to reverse the effects of the key misfolded proteins associated with all three dementia diseases...
Read More
Adrian Parton, MBE, of Boundary Capital has backed Capital Cell, Europe’s first dedicated Life Sciences crowdfunding platform. Capital Cell works with companies whose technology is based on biology or healthcare to secure the investment they need to progress their innovative, potentially life-changing ideas. Capital Cell’s model is to support early stage companies, with seed stage...
Read More
It’s easy to see how early-stage tech VC investing can make arguably the largest returns. If you get it right investing in a disruptive business like WhatsApp or Alibaba can generate huge exits: a whopping $22Bn and $25Bn respectively (Sequoia Capital turned $60 million into $3 billion thanks to WhatsApp). And not just in The...
Read More
Investors are looking for alternative strategies and techniques to improve earnings and reduce risk. We will look at how businesses can optimise their business model and gain traction for long-term sustainable growth – for the investor this means less risk, less capital needed and plenty of added value. Who is the event for? This event...
Read More
Portfolio company Pure Potions continue to go from strength to strength with products now being stocked in leading retailers Boots, QVC, Waitrose and Holland & Barrett. Pure Potions make products formulated especially for use by those prone to dry skin. Their creams, ointments and oils are made from the very finest ingredients – many of...
Read More
1 2 3 4 5 6 7

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases